$169.08
2.81[1.69%]
At close: May 16
$169.08
0[0.00%]
After Hours: 4:00PM EDT
Allstate Stock (NYSE:ALL), Analyst Ratings, Price Targets, Predictions
Allstate Corp has a consensus price target of $161.7, established from looking at the 100 latest analyst ratings. The last 3 analyst ratings were released from Wells Fargo, JP Morgan, and Morgan Stanley on May 10, 2024, May 2, 2024, and April 15, 2024. With an average price target of $178.67 between Wells Fargo, JP Morgan, and Morgan Stanley, there's an implied 5.67% upside for Allstate Corp from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Wells Fargo
JP Morgan
Morgan Stanley
Evercore ISI Group
Keefe, Bruyette & Woods
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Allstate
| Buy Now | Get Alert | |||||||
|---|---|---|---|---|---|---|---|---|
| 05/10/2024 | Buy Now | -9.51% | Wells Fargo | Elyse Greenspan | $146 → $153 | Maintains | Underweight | Get Alert |
| 05/02/2024 | Buy Now | 14.15% | JP Morgan | Jimmy Bhullar | $185 → $193 | Maintains | Overweight | Get Alert |
| 04/15/2024 | Buy Now | 12.37% | Morgan Stanley | Michael Phillips | $187 → $190 | Maintains | Overweight | Get Alert |
| 04/11/2024 | Buy Now | -13.65% | Wells Fargo | Elyse Greenspan | $145 → $146 | Maintains | Underweight | Get Alert |
| 04/11/2024 | Buy Now | 2.32% | Evercore ISI Group | Oliver Wintermantel | $166 → $173 | Maintains | In-Line | Get Alert |
| 04/10/2024 | Buy Now | 11.78% | Keefe, Bruyette & Woods | Meyer Shields | $181 → $189 | Maintains | Outperform | Get Alert |
| 04/08/2024 | Buy Now | 9.42% | JP Morgan | Jimmy Bhullar | $172 → $185 | Maintains | Overweight | Get Alert |
| 04/08/2024 | Buy Now | 18.29% | Roth MKM | Harry Fong | $175 → $200 | Reiterates | Buy → Buy | Get Alert |
| 04/01/2024 | Buy Now | 11.19% | Piper Sandler | Paul Newsome | $172 → $188 | Maintains | Overweight | Get Alert |
| 03/28/2024 | Buy Now | 12.37% | HSBC | Vikram Gandhi | → $190 | Upgrade | Hold → Buy | Get Alert |
| 03/25/2024 | Buy Now | 15.33% | Goldman Sachs | Alex Scott | $164 → $195 | Maintains | Buy | Get Alert |
| 02/14/2024 | Buy Now | 7.05% | Keefe, Bruyette & Woods | Meyer Shields | $171 → $181 | Maintains | Outperform | Get Alert |
| 02/12/2024 | Buy Now | 9.42% | UBS | Brian Meredith | $171 → $185 | Maintains | Buy | Get Alert |
| 02/09/2024 | Buy Now | -14.24% | Wells Fargo | Elyse Greenspan | $112 → $145 | Maintains | Underweight | Get Alert |
| 02/08/2024 | Buy Now | 1.73% | JP Morgan | Jimmy Bhullar | $164 → $172 | Maintains | Overweight | Get Alert |
| 01/22/2024 | Buy Now | 6.46% | Raymond James | C. Gregory Peters | $155 → $180 | Maintains | Strong Buy | Get Alert |
| 01/19/2024 | Buy Now | -6.55% | BMO Capital | Michael Zaremski | $140 → $158 | Maintains | Market Perform | Get Alert |
| 01/10/2024 | Buy Now | 1.14% | UBS | Brian Meredith | $160 → $171 | Maintains | Buy | Get Alert |
| 01/10/2024 | Buy Now | 14.15% | TD Cowen | Andrew Kligerman | → $193 | Initiates | → Outperform | Get Alert |
| 01/09/2024 | Buy Now | 6.46% | Jefferies | Yaron Kinar | $130 → $180 | Upgrade | Hold → Buy | Get Alert |
| 01/09/2024 | Buy Now | -3% | Goldman Sachs | Alex Scott | $141 → $164 | Maintains | Buy | Get Alert |
| 01/04/2024 | Buy Now | 1.14% | Morgan Stanley | Michael Phillips | $117 → $171 | Upgrade | Equal-Weight → Overweight | Get Alert |
| 12/28/2023 | Buy Now | -14.24% | HSBC | Vikram Gandhi | → $145 | Initiates | → Hold | Get Alert |
| 12/15/2023 | Buy Now | -17.2% | BMO Capital | Michael Zaremski | $125 → $140 | Maintains | Market Perform | Get Alert |
| 12/07/2023 | Buy Now | -5.37% | UBS | Brian Meredith | $152 → $160 | Maintains | Buy | Get Alert |
| 11/07/2023 | Buy Now | -16.61% | Goldman Sachs | Alex Scott | $128 → $141 | Maintains | Buy | Get Alert |
| 11/06/2023 | Buy Now | -8.33% | Raymond James | C. Gregory Peters | $145 → $155 | Maintains | Strong Buy | Get Alert |
| 11/03/2023 | Buy Now | -18.38% | Piper Sandler | Nicole Miller Regan | $137 → $138 | Maintains | Overweight | Get Alert |
| 11/03/2023 | Buy Now | -5.37% | Roth MKM | Harry Fong | $145 → $160 | Maintains | Buy | Get Alert |
| 10/20/2023 | Buy Now | -7.74% | Citigroup | Michael Ward | $135 → $156 | Maintains | Buy | Get Alert |
FAQ
What is the target price for Allstate (ALL)?
The latest price target for Allstate (NYSE: ALL) was reported by Wells Fargo on May 10, 2024. The analyst firm set a price target for $153.00 expecting ALL to fall to within 12 months (a possible -9.51% downside). 42 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Allstate (ALL)?
The latest analyst rating for Allstate (NYSE: ALL) was provided by Wells Fargo, and Allstate maintained their underweight rating.
When was the last upgrade for Allstate (ALL)?
The last upgrade for Allstate Corp happened on March 28, 2024 when HSBC raised their price target to $190. HSBC previously had a hold for Allstate Corp.
When was the last downgrade for Allstate (ALL)?
The last downgrade for Allstate Corp happened on October 21, 2022 when CFRA changed their price target from $132 to $130 for Allstate Corp.
When is the next analyst rating going to be posted or updated for Allstate (ALL)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Allstate, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Allstate was filed on May 10, 2024 so you should expect the next rating to be made available sometime around May 10, 2025.
Is the Analyst Rating Allstate (ALL) correct?
While ratings are subjective and will change, the latest Allstate (ALL) rating was a maintained with a price target of $146.00 to $153.00. The current price Allstate (ALL) is trading at is $169.08, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.